Research Papers – Page 5 – ONNOR Life Ltd

Research Papers RSS

Acetyl- L-Carnitine, Alzheimer's disease, vascular dementia -

CONCLUSION: Acetyl-L-carnitine (ALC) can be recommended in the abovementioned doses for treatment of early stages of Alzheimer’s disease and Vascular Dementia.

Read more

Acetyl- L-Carnitine, R-alpha-lipoic acid, RNA/DNA oxidation -

CONCLUSION: These results suggest that feeding ALCAR and LA to old rats improves performance on memory tasks by lowering oxidative damage and improving mitochondrial function.

Read more

Acetyl- L-Carnitine, Alzheimer's disease -

CONCLUSION: A recent meta-​-analysis of 21 double-​-blind clinical trials of acetyl carnitine in the treatment of mild cognitive impairment and mild Alzheimer's disease showed significant efficacy vs. placebo. A meta-​-analysis of 4 clinical trials of LA for treatment of neuropathic deficits in diabetes showed significant efficacy vs. placebo. 

Read more

Acetyl- L-Carnitine, depression -

Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.

CONCLUSION: “This investigation establishes that LAC is effective in counteracting symptoms of depression in the elderly. Relief of depressive symptomatology is expressed by decreased scores in the Hamilton Rating Scale for Depression and Beck Depression Inventory and by beneficial effects with regard to behavioural aspects”.

Read more

CUSTOMER SATISFACTION

If you are not 100% satisfied with your product please contact us.

SIGN UP TO ONNOR

Receive Early Access to Special Deals, Announcements and New Formulas